Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s): VYYRF

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd

Bullboard Posts

Comment by WarrantOfficeron Mar 27, 2020 11:27am

67 Views

Post# 30853025

RE:RE:Welcome VpharmCEO

VpharmCEO Thank you for your quick and candid response. One of my major concerns was ImagingX, it's requirement and place in the company flow chart. It's dissolution makes viable and economic sense. Contract with distributors will mean less cash flow, but will reduce expenditures in getting the product to market. You have a great proven plan and look forward to its fruition.

Respectfully:

WarrantOfficer

Bullboard Posts

Osisko Development receives permits for Cariboo Gold Project